Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients
Molecular Oncology · 2023
DOI: 10.1002/1878-0261.13415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2023. Verfasst von Mustafa Abdo und 16 weiteren Autor:innen. Beteiligte Einrichtung: LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplastic Cells, Circulating. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Skłodowska-Curie Actions.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Alternative sources of tumour information need to be explored in patients with non‐small cell lung cancer (NSCLC). Here, we compared programmed cell death ligand 1 ( PD‐L1 ) expression on cytology imprints and circulating tumour cells (CTCs) with PD‐L1 tumour proportion score (TPS) from immunohistochemistry staining of tumour tissue from patients with NSCLC. We evaluated PD‐L1 expression using a PD‐L1 antibody (28‐8) in representative cytology imprints, and tissue samples from the same tumour. We report good agreement rates on PD‐L1 positivity (TPS ≥ 1%) and high PD‐L1 expression (TPS ≥ 50%). Considering high PD‐L1 expression, cytology imprints showed a PPV of 64% and a NPV of 85%. CTCs were detected in 40% of the patients and 80% of them were PD‐L1 + . Seven patients with PD‐L1 expression of < 1% in tissue samples or cytology imprints had PD‐L1 + CTCs. The addition of PD‐L1 expression in CTCs to cytology imprints markedly improved the prediction capacity for PD‐L1 positivity. A combined analysis of cytological imprints and CTCs provides information on the tumoural PD‐L1 status in NSCLC patients, which might be used when no tumor tissue is available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
- Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Germany.
- Department of Respiratory Medicine, Agaplesion Diakonieklinikum Rotenburg, Germany.
- Department of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
- Institute of Pathology, University Hospital Schleswig-Holstein, Lübeck, Germany.
- Pathology, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
ORCID-Profile: Mustafa Abdo, Yassine Belloum
Förderung
- H2020 Marie Skłodowska-Curie Actions
Zitieren
APA
Abdo, M., Belloum, Y., Heigener, D., Welker, L., von Weihe, S., Schmidt, M., Heuer-Olewinski, N., Watermann, I., Szewczyk, M., Kropidlowski, J., Pereira-Veiga, T., Elmas, H., Perner, S., Steurer, S., Wikman, H., Pantel, K., & Reck, M. (2023). Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients. Molecular Oncology. https://doi.org/10.1002/1878-0261.13415
Vancouver
Abdo M, Belloum Y, Heigener D, Welker L, von Weihe S, Schmidt M, et al. Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients. Molecular Oncology. 2023. doi:10.1002/1878-0261.13415
BibTeX
@article{Abdo2023,
author = {Abdo, Mustafa and Belloum, Yassine and Heigener, David and Welker, Lutz and von Weihe, Sönke and Schmidt, Milena and Heuer-Olewinski, Nadine and Watermann, Iris and Szewczyk, Marlen and Kropidlowski, Jolanthe and Pereira-Veiga, Thais and Elmas, Hatice and Perner, Sven and Steurer, Stefan and Wikman, Harriet and Pantel, Klaus and Reck, Martin},
title = {Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients},
journal = {Molecular Oncology},
year = {2023},
doi = {10.1002/1878-0261.13415}
}
EUVIMED